Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 16, 2025 | BlossomHill Therapeutics | $84.0M Series B Extension | Brahma Capital, Vish Sridharan | Cormorant Asset Management, OrbiMed, Plaisance Capital Management, Vivo Capital |